RSV

RSV vaccine makers vying for market share in second year of shots
Reuters
Mon, 07/29/24 - 10:44 pm
Pfizer
GSK
Moderna Therapeutics
RSV
vaccines
Merck claims late-stage study success for RSV antibody
BioPharma Dive
Tue, 07/23/24 - 11:36 am
Merck
RSV
infants
clesrovimab
antibdodies
Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births
Reuters
Mon, 07/8/24 - 11:42 am
Pfizer
RSV
vaccines
pregnancy
preterm birth
real world data
CDC Narrows RSV Vaccine Recommendations for Seniors
BioSpace
Thu, 06/27/24 - 11:30 am
CDC
RSV
vaccines
Seniors
Moderna says its RSV shot is 50% effective across a second season
Reuters
Wed, 06/26/24 - 09:58 am
Moderna Therapeutics
vaccines
RSV
mRESVIA
MRNA
GSK loses out to Pfizer in supplying UK market with RSV vaccine
First Word Pharma
Mon, 06/24/24 - 11:21 am
GSK
Pfizer
RSV
vaccines
UK
GSK exec lauds 'great start' to RSV vaccine uptake as Arexvy nabs label expansion in adults 50-59
Fierce Pharma
Sat, 06/8/24 - 01:05 pm
GSK
Arexvy
vaccines
FDA
RSV
FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters
Sun, 06/2/24 - 02:50 pm
Moderna Therapeutics
FDA
RSV
vaccines
Where competition is heating up in pharma
Pharma Voice
Fri, 05/24/24 - 11:06 am
competition
oncology
immunology
COPD
RSV
ulcerative colitis
GSK
JNJ
Moderna Therapeutics
FDA delays decision on Moderna's RSV shot until the end of May
Fierce Biotech
Fri, 05/10/24 - 11:44 am
Moderna Therapeutics
FDA
RSV
vaccines
mRNA-1345
Moderna quarterly sales beat expectations
Reuters
Thu, 05/2/24 - 11:28 am
Moderna Therapeutics
earnings
RSV
vaccines
GSK's Arexvy maintains its RSV market dominance, looks to key label expansion as Moderna's mRNA threat looms
Fierce Pharma
Wed, 05/1/24 - 11:07 pm
GSK
RSV
vaccines
Pfizer
Arexvy
Abrysvo
Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data
BioSpace
Tue, 04/9/24 - 11:18 am
Pfizer
RSV
Abrysvo
clinical trials
vaccines
Blue Lake Biotechnology shares positive data from RSV vaccine trial
Clinical Trials Arena
Fri, 03/22/24 - 09:29 am
Blue Lake Biotechnology
vaccines
RSV
BLB201
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter
Stat
Thu, 03/7/24 - 05:35 pm
Sanofi
AstraZeneca
Beyfortus
RSV
monoclonal antibodies
RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest
Stat
Thu, 02/29/24 - 07:01 pm
RSV
vaccines
Pfizer
GSK
Guillain-Barré Syndrome
Pfizer's Abrysvo maintains strong efficacy through 2nd RSV season, study finds
Fierce Pharma
Thu, 02/29/24 - 09:43 am
Pfizer
RSV
vaccines
Abrysvo
Moderna posts surprise quarterly profit as it eyes RSV vaccine approval
Medical Marketing and Media
Thu, 02/22/24 - 11:49 am
Moderna Therapeutics
earnings
vaccines
RSV
COVID-19
Moderna shares slide as longer-term data shows quick fall in RSV vaccine efficacy
Reuters
Fri, 02/9/24 - 11:13 am
Moderna Therapeutics
vaccines
RSV
clinical trials
Veru needs additional cash for fresh trial of respiratory distress drug
Fierce Biotech
Thu, 02/8/24 - 11:09 am
Veru
respiratory distress
RSV
COVID-19
FDA

Pages